Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene ...
Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types